Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early mequitazine for chikungunya-associated arthritis pain
2006-006165-17Phase 3Active
- Sponsor
- Pierre Fabre Laboratories
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Chikungunya (CHIKV) comparing Mequitazine 10 mg/day with Placebo (2 arms). Primary endpoint: Painful arthritis symptoms over first 7 days. Started Nov 2006; status: active.
02
Drugs
Mequitazine
03
Conditions
Chikungunya (CHIKV)
Beyond the preview
Go deeper on 2006-006165-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006165-17.